Anticoagulation therapy

Intervention1 finding

C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.

1 lab in 1 country

Funder: Helse Sør-Øst RHF1 of 1 finding with company ties

Associations

1

Patch-based electrocardiogram sensor

upin humans1

1 study
  1. Patch-based electrocardiogram sensor is associated with anticoagulation therapy in humans (95.8% (366 of 382)).

    Human trialparticipants with screen-detected AFn = 382

    Digital recruitment and prevalence of screen-detected atrial fibrillation in nationwide patch-based ECG screening: the NORSCREEN randomized clinical trial · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 4 Aug 2026

Patch-based electrocardiogram sensor →